Skip to main content
PRLD logo

PRLD · Prelude Therapeutics Inc

$4.06 -0.14 (-3.33%) At close · Jul 20
Market Cap
$323.36M
Shares
79.65M

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

The Jun 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out.
Holders: 55
Total Value: $105,313,889
Total Shares: 30,793,416

Institutional Ownership Trend

24 quarters

Holder Concentration

Across 55 13F filers
Top Holder
35.4%
Jun 2023 → Mar 2026 · range 28.3% – 40.2%
of institutional value
Top 5
80.5%
Jun 2023 → Mar 2026 · range 77.2% – 88.5%
of institutional value
Top 10
89.4%
Jun 2023 → Mar 2026 · range 87.4% – 95.4%
of institutional value
HHI
2,413
Jun 2023 → Mar 2026 · range 1,836 – 3,057
Moderately concentrated
Showing 56 of 56
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1678660 CUSIP 74065P101 13F (30d) 2 filings 2 filers Visit website Investor relations